A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
Pharmacology effect
inhibítory fosfodiesteráz inhibítory agregácie trombocytov látky vazodilatačné
